Some of things we saw, and look, I think our core business, likely on the cost side, likely to - performs pretty consistent throughout the year, meaning a lot of things that have contributed to these costs will likely continue.
But look, we'll see a lot of the same contributors now. And then Q4 even accelerates beyond that. We're down $14 million, I'm not suggesting it's necessarily $14 million, but it does grow significantly off of Q2. And that's embedded in the guidance, so kind of flat, quarterly expense performance in this year. And obviously, we'll see meaningful pickup in spending. But we - we're still - we think we're on track just to - we're on track on those projects, and therefore I expect that money to be spent this year. We really haven't spent more than a couple of million dollars against that.
This post is fantastic Buy Disulfiram Online The spending for 2013 is largely ahead of us.
0 kommentar(er)
